🇺🇸 FDA
Patent

US 10695325

Compounds and methods for treating an epileptic disorder

granted A61KA61K31/137A61K31/19

Quick answer

US patent 10695325 (Compounds and methods for treating an epileptic disorder) held by The Regents of the University of California expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/137, A61K31/19, A61K31/195, A61K31/197